You and a guest will join David Cook , Steven Van Zandt, Maureen Van Zandt and friends for dinner at a top NYC restaurant on Monday, May 4th!
David Cook
After winning the Idol crown in season 7, Cook went on to sell 1.5 million copies of his self titled debut album. In 2008, David set Billboard records for debut entries by a male solo artist on the Billboard Hot 100 chart (with 11 titles), and for debut entries and total songs on the Hot Digital Songs chart (with 14 titles). David has toured extensively across the US and Southeast Asia in support of his multiple hit singles
Steven Van Zandt
An acclaimed musician, producer, songwriter, international DJ, activist, director, actor, and member of the Rock and Roll Hall of Fame, Steven Van Zandt is a founding member of Bruce Springsteen and the E Street Band, and recognized internationally as one of the world’s foremost authorities on both contemporary and traditional Rock and Roll.
Steven played Silvio Dante in HBO’s iconic series, “The Sopranos” and has just finished starring in, co-writing, executive producing, providing the music supervision, and scoring the third season of "Lilyhammer”, the award winning first original programming for Netflix.
Maureen Van Zandt
Maureen Van Zandt is co-artistic director/founder of Renegade Theatre Company, where she has produced, directed and acted in numerous productions. She appeared as Gabriella Dante in the HBO series The Sopranos for six seasons, and as Angelina Tagliano in the Netflix series Lilyhammer.
As a dancer, she has worked with ABT and the Metropolitan Opera Ballet and in the Broadway shows Hair, Phantom of The Opera, and Gypsy. She is director/ choreographer of the Sixties dance group, Garage Girls A Go Go, and recently served as dance supervisor for the film Not Fade Away.
Proceeds benefit David Cook’s Team for a Cure in the 2015 Race for Hope, the largest brain cancer community event in the world, which takes place on May 3rd in Washington, DC. The Race for Hope benefits Accelerate Brain Cancer Cure and the National Brain Tumor Society.